Can the risk of acetazolamide-induced aplastic anemia be decreased by periodic monitoring of blood cell counts?
Department Basic and Clinical Research, Research Institute of Scripps Clinic, La Jolla, CA 92037.
A
A
Zimran
E
E
Beutler
D000086:Acetazolamide / Q000009:adverse effects*; D000741:Anemia, Aplastic / Q000139:chemically induced*; D001772:Blood Cell Count; D005901:Glaucoma / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D012307:Risk Factors
D000086:Acetazolamide